NICOLE BAKER: Open Payments
NPI 1013550482 · WILLARD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$324 in 5 payments from 3 companies in 2025. Trend: 2023 $311 · 2024 $512 · 2025 $324
Food & beverage: $324
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $186 |
| GENZYME CORPORATION | 1 | $122 |
| Dexcom, Inc. | 1 | $15 |
Products named: FABRAZYME, FARXIGA, Dexcom G6 Transmitter.
Industry payments across MO — which companies pay providers there.
